Summary
Beam Therapeutics
Founded in 2017
Description
Beam Therapeutics is a biotechnology company that is revolutionizing gene-based editing. They are using CRISPR base editing technology to develop a broad portfolio of advanced genetic medicines. Their base editing technology allows for permanent, speci...
Strengths
- Beam Therapeutics has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Beam Therapeutics was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
Beam Therapeutics's annual revenue
$60920000
Based on Kona Equity data
-
Revenue per employee
$120157
-
Variance of revenue growth
151.99
-
Annual revenue growth since founding
$8702857
-
Revenue growth rate from first known quarter to current
1049.2%
Employee Count
507 employees
-
Employee growth rate from first known quarter to current
987.5%
Executives
G Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
1.05 M
-
Page views per visitor
4.0
-
Daily time
2:43
-
Bounce Rate
52.9 %
Location
Unlock unlimited leads
Similar Companies
Editas Medicine Inc
editasmedicine.com- Founded in 2013
- Location: Cambridge, MA
- Annual Revenue: $19.7M
- Employees: 226
- Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases. They are pioneering the use of CRISPR gene editing to develop a robust pipeline of transformative genomic medicines for various d...
Generation Bio Co
generationbio.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $50.6M
- Employees: 150
- Generation Bio is a biotechnology company that is pushing the limits of genetic medicine. They are focused on providing durable, redosable treatments for people living with rare and prevalent diseases. Their non-viral platform incorporates a novel DNA ...
Vor Biopharma
vorbio.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $45.6M
- Employees: 135
- Engineered hematopoietic stem cells that unleash the potential of targeted therapies. Hide healthy cells, expose cancer cells.
Homology Medicines
homologymedicines.com- Founded in 2015
- Location: Bedford, MA
- Annual Revenue: $5.5M
- Employees: 224
- Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, de...
Intellia Therapeutics Inc
intelliatx.com- Founded in 2014
- Location: Cambridge, MA
- Annual Revenue: $52.1M
- Employees: 598
- Intellia Therapeutics, a leading clinical stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR based technologies. We're a #GenomeEditing company, developing novel, potentially curative therapeutics lev...
Alector, Inc.
alector.com- Founded in 2013
- Location: South San Francisco, CA
- Annual Revenue: $227.4M
- Employees: 237
- Alector Therapeutics is a biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases. They combine state-of-the-art antibody technology with recent discoveries in neuroimmunology and human genetics to develop nove...
Key Information
- Name: Beam Therapeutics
- Category: Biotechnology
- Industry: Pharmaceutical company
- SIC: 87; 873
- NAICS: 54; 541
Disclaimer: These numbers are estimates and any other company information
is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona
Equity is in no way affiliated with Beam Therapeutics.
See similar companies
-
By City Cambridge Small Pharmaceutical company in Cambridge Mid-size Pharmaceutical company in Cambridge Biotechnology in Cambridge Small Biotechnology in Cambridge Mid-size Biotechnology in Cambridge
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA Small Pharmaceutical company in MA Mid-size Pharmaceutical company in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Pharmaceutical company Small Pharmaceutical company Mid-size Pharmaceutical company Biotechnology and Pharmaceutical company
-
Firmographic data G Score of 6 Founded in 2017 SIC: 87 SIC: 873 NAICS: 54 NAICS: 541 #Business Services #Research & Development
Frequently Asked Questions
Where is Beam Therapeutics located?
Beam Therapeutics's headquarters are located at 238 Main St Fl 9 Cambridge, MA 02142.
What is Beam Therapeutics's official website?
Beam Therapeutics's official website is beamtx.com
What is Beam Therapeutics's revenue?
Beam Therapeutics's annual revenue is $60.9 M.
What is Beam Therapeutics's SIC code?
Beam Therapeutics's SIC: 87; 873
What is Beam Therapeutics's NAICS code?
Beam Therapeutics's NAICS: 54; 541.
How many employees does Beam Therapeutics's have?
Beam Therapeutics has 507 employees
What industry does Beam Therapeutics belong to?
Beam Therapeutics is in the industry of Biotechnology.
